Biovie Inc.
BIVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580149
In the last 90 days, Biovie Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $2.86M in total; no superinvestor holds it.
Other share classesBIVIW
13F holders, Q3 2022
Institutional positions in Biovie Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +2 vs. Q2 2022
- Shares held
- 480.3K
- −619.8K (−56.3%) vs. Q2 2022
- Total value
- $1.20M
- −$404.7K (−25.3%) vs. Q2 2022
- New holders
- 4
- 7 more added
- Sold out
- 2
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $2.86M |
| Q1 2026 | 33 | $1.44M |
| Q4 2025 | 35 | $1.34M |
| Q3 2025 | 32 | $2.28M |
| Q2 2025 | 38 | $1.02M |
| Q1 2025 | 37 | $968.2K |
| Q4 2024 | 43 | $1.52M |
| Q3 2024 | 27 | $195.2K |
| Q2 2024 | 50 | $1.79M |
| Q1 2024 | 51 | $3.55M |
| Q4 2023 | 54 | $2.32M |
| Q3 2023 | 57 | $5.95M |
| Q2 2023 | 53 | $8.29M |
| Q1 2023 | 48 | $13.0M |
| Q4 2022 | 39 | $9.50M |
| Q3 2022 | 18 | $1.20M |
| Q2 2022 | 16 | $1.60M |
| Q1 2022 | 14 | $7.14M |
| Q4 2021 | 15 | $7.45M |
| Q3 2021 | 14 | $9.96M |
| Q2 2021 | 12 | $4.85M |
| Q1 2021 | 13 | $4.62M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Biovie Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| swisspartners Ltd. | 161,000 | $401.0K | 0.41% | 00.0% | Unchanged |
| Sabby Management, LLC | 98,048 | $244.0K | 0.53% | −529,322−84.4% | Reduced |
| Geode Capital Management, LLC | 39,438 | $98.0K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 36,617 | $91.0K | 0.01% | +36,617 | New |
| Vanguard Group Inc | 34,779 | $86.0K | 0.00% | −129,701−78.9% | Reduced |
| Renaissance Technologies LLC | 23,500 | $59.0K | 0.00% | +7,500+46.9% | Added |
| Long Focus Capital Management, LLC | 20,000 | $50.0K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 17,634 | $43.0K | 0.00% | +17,634 | New |
| State Street Corp | 15,112 | $38.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 10,000 | $25.0K | 0.00% | +10,000 | New |
| BlackRock Inc. | 9,123 | $22.0K | 0.00% | −265−2.8% | Reduced |
| Tower Research Capital LLC (TRC) | 5,939 | $15.0K | 0.00% | +1,752+41.8% | Added |
| Advisor Group Holdings, Inc. | 3,038 | $8.00K | 0.00% | +2,700+798.8% | Added |
| Wells Fargo & Company | 2,685 | $7.00K | 0.00% | +2+0.1% | Added |
| Morgan Stanley | 2,103 | $5.00K | 0.00% | +603+40.2% | Added |
| Barrett & Company, Inc. | 300 | $2.33K | 0.00% | +300 | New |
| UBS Group AG | 928 | $2.00K | 0.00% | +671+261.1% | Added |
| Royal Bank of Canada | 93 | $0 | 0.00% | +60+181.8% | Added |
| Kepos Capital LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,339−100.0% | Sold out |